Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients

Liver International

Volumn 30, Issue 1, 2010, Pages 112-118

  Li, Yajuan ^a   Xie, Qing ^a   Lu, Fengmin ^a   Zhao, Jingmin ^b   Mao, Panyong ^b   Li, Zhuo ^c   Liu, Shuang ^c   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING 302 HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

EGF; EGF expression; Hepatocellular carcinoma; Polymorphisms

Indexed keywords

ADENINE; EPIDERMAL GROWTH FACTOR; GUANINE;

ADULT; AGED; ARTICLE; CHINESE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 73449101097     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02134.x     Document Type: Article

References (31)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
2. El-Serag HB, Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76.
3. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009; 122: 3-4.
4. Coleman W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3: 573-88.
5. Jorissen RN, Walker F, Pouliot N, et al. Epidermal growth factor receptor: mechanisms of activation and signaling. Exp Cell Res 2003; 284: 31-53.
6. Shiraga M, Komatsu N, Teshigawara K, et al. Growth factor stimulates proliferation of mouse uterine epithelial cells in primary culture. Zool Sci 2000; 17: 661-6.
7. Limaye PB, Bowen WC, Orr AV, et al. Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology 2008; 47: 1702-13.
8. Stoscheck CM, King LE Jr. Role of epidermal growth factor in carcinogenesis. Cancer Res 1986; 46: 1030-7.
9. Yoshida K, Kyo E, Tsuda T, et al. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Int J Cancer 1990; 45: 131-5.
10. Blanc P, Etienne H, Daujat M, et al. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology 1992; 102: 1340-50.
11. Mullhaupt B, Feren A, Fodor E, Jones A. Liver expression of epidermal growth factor R.N.A. Rapid increases in immediate-early phase of liver regeneration. J Biol Chem 1994; 269: 19667-70.
12. Tönjes RR, Löhler J, O'Sullivan JF, et al. Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene 1995; 10: 765-8.
13. Hung WC, Chuang LY, Tsai JH, Chang C.C. Effects of epidermal growth factor on growth control and signal transduction pathways in different human hepatoma cell lines. Biochem Mol Biol Int 1993; 30: 319-28.
14. Daveau M, Scotte M, Francois A, et al. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog 2003; 36: 130-41.
15. Ito Y, Takeda T, Sakon M, et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer 2001; 84: 1377-83.
16. Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002; 359: 397-401.
17. Bhowmick DA, Zhuang Z, Wait SD, Weil R.J. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004; 64: 1220-3.
18. Hamai Y, Matsumura S, Matsusaki K, et al. A single nucleotide polymorphism in the 50 untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 2005; 72: 133-8.
19. Tanabe KK, Lemoine A, Finkelstein DM, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008; 299: 53-60.
20. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
21. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor+61A>G and transforming growth factor beta1(509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008; 69: 360-7.
22. Okamoto I, Roka F, Krögler J, et al. The EGF A61G polymorphism is associated with disease free period and survival in malignant melanoma. J Invest Dermatol 2006; 126: 2242-6.
23. Jain M, Kumar S, Upadhyay R, et al. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 2007; 6: 1553-8.
24. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
25. Chen CJ, Iloeje UH, Yang H.I. Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis 2007; 11: 797-816.
26. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-86.
27. Amend KL, Elder JT, Tomsho LP, et al. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 2004; 64: 2668-72.
28. Vauleon E, Auger N, Benouaich-Amiel A, et al. The 61A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 2007; 172: 33-7.
29. Kang S, Kim JW, Park NH, et al. Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer 2007; 17: 492-6.
30. Jin G, Miao R, Deng Y, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 2007; 98: 864-8.
31. Liu XQ, Li L, Chen XM, et al. No association between EGF 161 A/G polymorphism and increased risk of glioma. Int J Biol Markers 2009; 24: 77-83.